Ishita Drugs and Industries Limited (BOM:524400)
India · Delayed Price · Currency is INR 76.54
+0.54 (0.71%)
At close: Aug 21, 2026
BOM:524400 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 229 | 207 | 235 | 196 | 148 | 124 | |
Market Cap Growth | 3.32% | -12.01% | 19.76% | 32.70% | 19.52% | 37.83% |
Enterprise Value | 162 | 120 | 150 | 139 | 82 | 61 |
Last Close Price | 76.54 | 69.11 | 78.54 | 65.58 | 49.42 | 41.35 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 32.43 | 26.55 | 27.06 | 26.20 | 25.59 | 15.36 |
PS Ratio | 1.85 | 1.41 | 1.57 | 1.29 | 1.22 | 0.88 |
PB Ratio | 1.98 | 1.79 | 2.18 | 1.98 | 1.61 | 1.44 |
P/TBV Ratio | 1.98 | 1.79 | 2.18 | 1.98 | 1.61 | 1.44 |
P/FCF Ratio | 11.06 | 9.99 | - | 9.37 | - | 4.04 |
P/OCF Ratio | 5.84 | 5.27 | - | 9.25 | - | 4.02 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.30 | 0.82 | 1.00 | 0.91 | 0.68 | 0.43 |
EV/EBITDA Ratio | 22.71 | 15.63 | 14.98 | 15.25 | 10.79 | 5.57 |
EV/EBIT Ratio | 26.29 | 17.97 | 16.83 | 17.39 | 13.00 | 6.32 |
EV/FCF Ratio | 7.82 | 5.79 | - | 6.62 | - | 1.99 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.36 | - | 0.11 | - |
Debt / EBITDA Ratio | 0.11 | 0.11 | 3.90 | - | 1.26 | - |
Debt / FCF Ratio | - | 0.04 | - | - | - | - |
Net Debt / Equity Ratio | -0.58 | -0.58 | -0.41 | -0.79 | -0.61 | -0.66 |
Net Debt / EBITDA Ratio | -9.43 | -8.77 | -4.44 | -8.67 | -7.34 | -5.18 |
Net Debt / FCF Ratio | - | -3.25 | 1.16 | -3.76 | 1.84 | -1.85 |
Asset Turnover | - | 1.01 | 1.11 | 1.37 | 1.07 | 1.37 |
Inventory Turnover | - | 3.83 | 4.56 | 9.72 | 3.71 | 5.31 |
Quick Ratio | - | 7.90 | 1.90 | 9.89 | 3.77 | 2.36 |
Current Ratio | - | 9.65 | 2.77 | 11.14 | 4.60 | 3.82 |
Return on Equity (ROE) | - | 6.96% | 8.38% | 7.84% | 6.50% | 9.83% |
Return on Assets (ROA) | - | 2.88% | 4.11% | 4.48% | 3.49% | 5.86% |
Return on Invested Capital (ROIC) | 9.02% | 8.58% | 15.97% | 21.46% | 14.37% | 27.74% |
Return on Capital Employed (ROCE) | - | 5.70% | 8.20% | 8.00% | 6.90% | 11.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.09% | 3.77% | 3.70% | 3.82% | 3.91% | 6.51% |
FCF Yield | 9.04% | 10.01% | -16.27% | 10.68% | -20.51% | 24.73% |
Buyback Yield / Dilution | - | -0.13% | - | - | - | - |